79.75 -0.38 (-0.47%)
After hours: 5:57PM EDT
|Bid||79.80 x 1400|
|Ask||81.05 x 1000|
|Day's range||78.92 - 80.54|
|52-week range||70.73 - 93.37|
|Beta (3Y Monthly)||0.32|
|PE ratio (TTM)||21.83|
|Earnings date||19 Oct 2018|
|Forward dividend & yield||2.87 (3.64%)|
|1y target est||84.03|
Kimberly-Clark’s (KMB) profit margins haven’t impressed investors in the past several quarters. The company continues to struggle on the margins front. Lower pricing, increased commodity and shipping costs, and soft volumes have taken a toll on the company’s profitability.
Analysts expect Kimberly-Clark (KMB) to report total revenues of $4.5 billion in the third quarter—down 2.1% compared to the same period last year. Analysts expect soft volumes and weak pricing to continue to hurt the company’s organic sales growth rate and overall sales. Negative currency rates pose a threat to the top line in the third quarter.
Kimberly-Clark (KMB) is scheduled to announce to its third-quarter results on October 22. However, analysts’ estimate for the third quarter reflects that the company will likely disappoint investors with its sales and earnings performance.
The consumer products giant is working hard to get sales growth back on track -- here's what investors need to watch in the fiscal Q1 earnings.
Procter & Gamble (PG) is scheduled to announce its results for the first quarter of 2019 on October 19. However, analysts expect the company to disappoint investors on all fronts including sales, margins, and earnings. Analysts expect Procter & Gamble to report total revenues of $16.5 billion—a decrease of 0.8% YoY (year-over-year).
Wall Street analysts are maintaining a neutral outlook on Procter & Gamble (PG) stock. Of the 24 analysts tracking PG stock, 17 analysts recommend a “hold” rating, six analysts suggest a “buy,” and one analyst recommends a “sell.” Analysts have a consensus target price of $84.08 per share on PG stock, which indicates an upside of 3.2% based on its closing price of $81.44 on October 10.
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shares of consumer packaged goods manufacturers in the United States have decline considerably in the past few days. Deutsche Bank turned negative on the prospects of the companies operating in the consumer packaged goods sector on October 10.
P&G (PG) benefits from higher demand for skincare products along with fabric and home care products. However, softness in grooming and baby care businesses, and recent pricing actions are concerns.
So far, Procter & Gamble (PG) has impressed with its bottom-line performance and has a strong track record of exceeding analysts’ expectations. Procter & Gamble has exceeded analysts’ earnings estimates in the last 13 consecutive quarters, with an average earnings surprise of 4.4%. This performance comes amid a weak sales and margins environment.
Procter & Gamble’s (PG) profit margins haven’t impressed over the past several quarters. The company has struggled on the margins front despite generating significant cost and productivity savings. Procter & Gamble’s gross profit margins have worsened sequentially, as shown in the chart below, with the rate of decline increasing each quarter. Lower pricing and increased manufacturing, packaging, and supply-chain costs have taken a toll on the profitability of consumer packaged goods manufacturers in the United States.
Procter & Gamble (PG) hasn’t impressed with its top-line performance in the past several quarters, and analysts don’t expect this trend to change soon. Analysts expect Procter & Gamble’s top line to remain weak at least in the first half of fiscal 2019, marking a YoY (year-over-year) decline. Analysts expect Procter & Gamble (PG) to report net sales of $16.5 billion in the first quarter of fiscal 2019, which implies a YoY decline of 0.8%.
On October 19, Procter & Gamble (PG) plans to announce its earnings for the first quarter of fiscal 2019, which ended on September 30. However, analysts have a dim outlook for the quarter, which could hurt investor sentiment and PG stock.
Johnson & Johnson (JNJ) is scheduled to report its third-quarter earnings on October 16. The company’s second-quarter growth in its Consumer business was below expectations. However, it expects to accelerate the segment’s growth in the second half of the year, driven mainly by the introduction of new products. The company’s other two business segments are Pharmaceuticals and Medical Devices. Johnson & Johnson’s Consumer business consists of a range of products across its baby care, oral care, women’s health, beauty, wound care, and over-the-counter franchises.
NEW YORK, Oct. 11, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Trian said Tuesday that it controls 7 million shares, about 2.9 percent of the paintmaker’s outstanding stock. After a regulatory filing disclosing that it had held a $269 million stake as of June 30, Trian said in an emailed statement that its current position was worth $690 million. Trian said in August that it had taken a new position in a company that it didn’t identify on its quarterly investment filings after reaching an agreement with regulators to keep it confidential.
General Mills, JCPenney, and Procter & Gamble could all lose customers to Amazon’s growing portfolio of private label brands.
Activist investor Nelson Peltz had been agitating for a spot on P&G’s board as he called for a long list of changes, and the consumer-goods giant had spent big money to try secure enough votes to deny him a seat at the table. Ultimately, after an extremely close vote, Peltz ended up joining the board, and the feeling was that things were going to change. P&G’s baby-care business had a particularly rough year, as its Luvs brand was pummeled in the U.S. by private-label diaper lines with ultra-low price tags. And the Gillette razor business remains under pressure several years after Dollar Shave Club and others of its ilk first began rattling the market share leader.
On October 8, Goldman Sachs downgraded Kimberly-Clark (KMB) stock to “neutral” from “buy” and lowered the target price from $120 to $119 per share. Continued inflation in input cost and weakness in the personal care segment could restrict the growth for Kimberly-Clark. Also, the company’s current valuations don’t seem attractive. Kimberly-Clark stock trades at 17.2x the estimated 2018 EPS of $6.66 and 16.3x the estimated 2019 EPS of $6.99. Both these multiples look expensive based on the projected growth rate of 6.9% and 5.0% in those periods.
The Zacks Analyst Blog Highlights: Cisco, Procter & Gamble, Citigroup, Qualcomm and General Electric